CHAD BOOMERSHINE
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology
- Where
- Bellbrook, OH
- NPI
- 1457408304
- Received
- $9,699 in 73 records, 2019 to 2024
- As principal investigator
- $94,969 of research payments to others in 24 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2023 | General payment | 1 | $15 |
| 2022 | General payment | 13 | $230 |
| 2021 | General payment | 26 | $4,343 |
| 2020 | General payment | 12 | $197 |
| 2019 | General payment | 21 | $4,911 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| PFIZER INC. | 2 | $4,486 | 2019 |
| Regeneron Pharmaceuticals, Inc. | 1 | $3,880 | 2021 |
| UCB, Inc. | 13 | $282 | 2019–2022 |
| Regeneron Healthcare Solutions, Inc. | 7 | $120 | 2019 |
| ABBVIE INC. | 6 | $117 | 2020–2022 |
| Amgen Inc. | 6 | $110 | 2020–2022 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $89 | 2020–2022 |
| Lilly USA, LLC | 2 | $87 | 2019 |
| Almatica Pharma LLC | 3 | $57 | 2021 |
| Horizon Therapeutics plc | 4 | $51 | 2019–2020 |
| Mallinckrodt Hospital Products Inc. | 2 | $45 | 2020 |
| Sentynl Therapeutics, Inc. | 3 | $43 | 2019–2020 |
| SCILEX PHARMACEUTICALS INC. | 1 | $41 | 2019 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 | 2020–2021 |
| Abbott Laboratories | 2 | $32 | 2021–2023 |
| BioDelivery Sciences International, Inc. | 2 | $32 | 2021 |
| IBSA Pharma Inc. | 2 | $31 | 2021–2022 |
| Alexion Pharmaceuticals, Inc. | 1 | $20 | 2020 |
| Gilead Sciences, Inc. | 1 | $19 | 2020 |
| Janssen Biotech, Inc. | 1 | $19 | 2019 |
| Virtus Pharmaceuticals LLC | 1 | $18 | 2021 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 | 2021 |
| RedHill Biopharma Inc. | 1 | $15 | 2022 |
| Nevro Corp. | 1 | $13 | 2019 |
| Zyla Life Sciences, Inc. | 1 | $13 | 2019 |
| Radius Health, Inc. | 1 | $12 | 2021 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Consulting Fee | 2 | $8,030 |
| Food and Beverage | 69 | $1,317 |
| Travel and Lodging | 1 | $336 |
| Education | 1 | $15 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2023-01-31 | Abbott Laboratories | $15 | Food and Beverage | In-kind items and services | PROCLAIM Device, Neuromodulation | 2023 | |
| 2022-03-31 | Amgen Inc. | $12 | Food and Beverage | In-kind items and services | Enbrel Biological, Inflammation | 2022 | |
| 2022-03-22 | UCB, Inc. | $16 | Food and Beverage | In-kind items and services | Cimzia Drug, Immunology | 2022 | |
| 2022-03-22 | UCB, Inc. | $1 | Food and Beverage | In-kind items and services | Cimzia Drug, Immunology | 2022 | |
| 2022-03-15 | Amgen Inc. | $20 | Food and Beverage | In-kind items and services | Enbrel Biological, Inflammation | 2022 | |
| 2022-03-09 | UCB, Inc. | $24 | Food and Beverage | In-kind items and services | Cimzia Drug, Immunology | 2022 | |
| 2022-03-01 | RedHill Biopharma Inc. | $15 | Food and Beverage | In-kind items and services | Movantik Drug, Opioid Antagonist | 2022 | |
| 2022-02-15 | UCB, Inc. | $15 | Food and Beverage | In-kind items and services | Cimzia Drug, Immunology | 2022 | |
| 2022-02-09 | UCB, Inc. | $28 | Food and Beverage | In-kind items and services | Cimzia Drug, Immunology | 2022 | |
| 2022-01-25 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2022 | |
| 2022-01-18 | IBSA Pharma Inc. | $15 | Food and Beverage | Cash or cash equivalent | Licart Drug, non-opioid analgesic | 2022 | |
| 2022-01-17 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15 | Food and Beverage | In-kind items and services | RELISTOR Drug, Gastroenterology | 2022 | |
| 2022-01-11 | UCB, Inc. | $11 | Food and Beverage | In-kind items and services | Cimzia Drug, Immunology | 2022 | |
| 2022-01-04 | UCB, Inc. | $23 | Food and Beverage | In-kind items and services | Cimzia Drug, Immunology | 2022 | |
| 2021-12-22 | AstraZeneca Pharmaceuticals LP | $23 | Food and Beverage | In-kind items and services | SAPHNELO Biological, Inflammation and Autoimmunity | 2021 | |
| 2021-12-20 | UCB, Inc. | $25 | Food and Beverage | In-kind items and services | Cimzia Drug, Immunology | 2021 | |
| 2021-11-23 | UCB, Inc. | $29 | Food and Beverage | In-kind items and services | Cimzia Drug, Immunology | 2021 | |
| 2021-11-17 | UCB, Inc. | $16 | Food and Beverage | In-kind items and services | Cimzia Drug, Immunology | 2021 | |
| 2021-11-09 | Abbott Laboratories | $17 | Food and Beverage | In-kind items and services | Proclaim IPG Device, Neuromodulation | 2021 | |
| 2021-11-02 | Amgen Inc. | $23 | Food and Beverage | In-kind items and services | Enbrel Biological, Inflammation | 2021 | |
| 2021-10-19 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2021 | |
| 2021-10-04 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14 | Food and Beverage | In-kind items and services | RELISTOR Drug, Gastroenterology | 2021 | |
| 2021-08-31 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2021 | |
| 2021-08-24 | Almatica Pharma LLC | $19 | Food and Beverage | In-kind items and services | GRALISE Drug, POSTHERPETIC NEURALGIA | 2021 | |
| 2021-08-10 | Radius Health, Inc. | $12 | Food and Beverage | In-kind items and services | Tymlos Biological, Endocrinology | 2021 | |
| 2021-08-03 | Amgen Inc. | $18 | Food and Beverage | In-kind items and services | Enbrel Biological, Inflammation | 2021 | |
| 2021-07-14 | UCB, Inc. | $16 | Food and Beverage | In-kind items and services | Cimzia Drug, Immunology | 2021 | |
| 2021-06-29 | Arbor Pharmaceuticals, Inc. | $15 | Food and Beverage | In-kind items and services | Horizant Drug, Sleep | 2021 | |
| 2021-06-18 | BioDelivery Sciences International, Inc. | $17 | Food and Beverage | In-kind items and services | BELBUCA Drug, Chronic Pain | 2021 | |
| 2021-05-20 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $13 | Food and Beverage | In-kind items and services | RELISTOR Drug, Gastroenterology | 2021 | |
| 2021-05-11 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2021 | |
| 2021-04-13 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | RINVOQ Biological, IMMUNOLOGY | 2021 | |
| 2021-04-06 | Amgen Inc. | $20 | Food and Beverage | In-kind items and services | Enbrel Biological, Inflammation | 2021 | |
| 2021-03-31 | IBSA Pharma Inc. | $16 | Food and Beverage | Cash or cash equivalent | Licart Drug, non-opioid analgesic | 2021 | |
| 2021-03-26 | Regeneron Pharmaceuticals, Inc. | $3,880 | Consulting Fee | Cash or cash equivalent | 2021 | ||
| 2021-03-23 | Virtus Pharmaceuticals LLC | $18 | Food and Beverage | In-kind items and services | LEVORPHANOL TARTRATE Drug, ANALGESICS - OPIOID | 2021 | |
| 2021-03-10 | Almatica Pharma LLC | $19 | Food and Beverage | In-kind items and services | NAPRELAN Drug, ANALGESIC | 2021 | |
| 2021-02-17 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16 | Food and Beverage | In-kind items and services | RELISTOR Drug, Gastroenterology | 2021 | |
| 2021-01-26 | Almatica Pharma LLC | $18 | Food and Beverage | In-kind items and services | NAPRELAN Drug, ANALGESIC | 2021 | |
| 2021-01-19 | BioDelivery Sciences International, Inc. | $14 | Food and Beverage | In-kind items and services | BELBUCA Drug, Chronic Pain | 2021 | |
| 2020-12-11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18 | Food and Beverage | In-kind items and services | RELISTOR Drug, GASTROENTEROLOGY | 2020 | |
| 2020-11-17 | Mallinckrodt Hospital Products Inc. | $29 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2020 | |
| 2020-10-26 | Amgen Inc. | $15 | Education | In-kind items and services | Otezla Drug, Inflammation | 2020 | |
| 2020-08-18 | Alexion Pharmaceuticals, Inc. | $20 | Food and Beverage | In-kind items and services | Strensiq Drug, Endocrinology | 2020 | |
| 2020-07-31 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $12 | Food and Beverage | In-kind items and services | RELISTOR Drug, GASTROENTEROLOGY | 2020 | |
| 2020-07-22 | Gilead Sciences, Inc. | $19 | Food and Beverage | In-kind items and services | 2020 | ||
| 2020-05-28 | Mallinckrodt Hospital Products Inc. | $16 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2020 | |
| 2020-03-03 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | HUMIRA Biological, IMMUNOLOGY | 2020 | |
| 2020-02-18 | Horizon Therapeutics plc | $12 | Food and Beverage | In-kind items and services | RAYOS Drug, RAYOS | 2020 | |
| 2020-02-11 | Sentynl Therapeutics, Inc. | $13 | Food and Beverage | In-kind items and services | LEVORPHANOL TARTRATE Drug, Pharmacology/Toxicology | 2020 | |
| 2020-01-21 | AstraZeneca Pharmaceuticals LP | $15 | Food and Beverage | In-kind items and services | MOVANTIK Drug, Neuroscience | 2020 | |
| 2020-01-07 | Horizon Therapeutics plc | $12 | Food and Beverage | In-kind items and services | RAYOS Drug, RAYOS | 2020 | |
| 2019-12-23 | PFIZER INC. | $4,150 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-12-10 | PFIZER INC. | $336 | Travel and Lodging | In-kind items and services | 2019 | ||
| 2019-12-10 | Regeneron Healthcare Solutions, Inc. | $16 | Food and Beverage | In-kind items and services | KEVZARA Biological, INFLAMMATION AND IMMUNOLOGY | 2019 | |
| 2019-11-19 | Nevro Corp. | $13 | Food and Beverage | In-kind items and services | Senza Spinal Cord Stimulation System Device, Spinal Cord Stimulator | 2019 | |
| 2019-11-05 | Regeneron Healthcare Solutions, Inc. | $21 | Food and Beverage | In-kind items and services | KEVZARA Biological, INFLAMMATION AND IMMUNOLOGY | 2019 | |
| 2019-10-24 | UCB, Inc. | $27 | Food and Beverage | In-kind items and services | Cimzia Drug, Immunology | 2019 | |
| 2019-10-15 | Sentynl Therapeutics, Inc. | $13 | Food and Beverage | In-kind items and services | Levorphanol Tartrate Drug, Pharmacology/Toxicology | 2019 | |
| 2019-10-08 | Regeneron Healthcare Solutions, Inc. | $16 | Food and Beverage | In-kind items and services | KEVZARA Biological, INFLAMMATION AND IMMUNOLOGY | 2019 | |
| 2019-09-19 | Lilly USA, LLC | $74 | Food and Beverage | In-kind items and services | TALTZ Drug, Immunology | 2019 | |
| 2019-09-19 | Lilly USA, LLC | $12 | Food and Beverage | In-kind items and services | TALTZ Drug, Immunology | 2019 | |
| 2019-09-10 | Regeneron Healthcare Solutions, Inc. | $17 | Food and Beverage | In-kind items and services | KEVZARA Biological, INFLAMMATION AND IMMUNOLOGY | 2019 | |
| 2019-09-05 | Horizon Therapeutics plc | $14 | Food and Beverage | In-kind items and services | RAYOS Drug, RAYOS | 2019 | |
| 2019-08-09 | Regeneron Healthcare Solutions, Inc. | $17 | Food and Beverage | In-kind items and services | KEVZARA Biological, INFLAMMATION AND IMMUNOLOGY | 2019 | |
| 2019-07-23 | Regeneron Healthcare Solutions, Inc. | $16 | Food and Beverage | In-kind items and services | KEVZARA Biological, INFLAMMATION AND IMMUNOLOGY | 2019 | |
| 2019-07-02 | Horizon Therapeutics plc | $12 | Food and Beverage | In-kind items and services | RAYOS Drug, RAYOS | 2019 | |
| 2019-06-11 | Regeneron Healthcare Solutions, Inc. | $16 | Food and Beverage | In-kind items and services | KEVZARA Biological, INFLAMMATION AND IMMUNOLOGY | 2019 | |
| 2019-06-01 | SCILEX PHARMACEUTICALS INC. | $41 | Food and Beverage | In-kind items and services | ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH Drug, Analgesic | 2019 | |
| 2019-05-20 | UCB, Inc. | $45 | Food and Beverage | In-kind items and services | Cimzia Drug, Immunology | 2019 | |
| 2019-05-14 | Sentynl Therapeutics, Inc. | $16 | Food and Beverage | In-kind items and services | Levorphanol Tartrate Drug, Pharmacology/Toxicology | 2019 | |
| 2019-04-18 | Janssen Biotech, Inc. | $19 | Food and Beverage | In-kind items and services | SIMPONI Biological, Immunology | 2019 | |
| 2019-01-17 | Zyla Life Sciences, Inc. | $13 | Food and Beverage | In-kind items and services | SPRIX Drug, Pain Medicine | 2019 |
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2024-09-09 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $165 | Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2024 |
| 2024-08-12 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $838 | Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2024 |
| 2024-08-12 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $1,676 | Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2024 |
| 2024-08-05 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $838 | Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2024 |
| 2024-07-22 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $525 | Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2024 |
| 2024-07-22 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $2,050 | Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2024 |
| 2024-07-08 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $838 | Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2024 |
| 2023-10-16 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $2,695 | Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2023 |
| 2023-10-03 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $1,145 | Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2023 |
| 2023-09-11 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $2,695 | Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2023 |
| 2023-08-28 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $838 | Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2023 |
| 2023-08-28 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $838 | Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2023 |
| 2023-08-21 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $2,695 | Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2023 |
| 2023-08-14 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $34,980 | Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2023 |
| 2023-08-14 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $2,695 | Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2023 |
| 2023-04-17 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $14,564 | Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2023 |
| 2023-04-04 | SANOFI US SERVICES INC. | CARE ACCESS RESEARCH LLC | $14,564 | Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerab | 2023 |
| 2023-01-24 | Amgen Inc. | CARE ACCESS RESEARCH LLC | $2,033 | P0 ASCVD Olpasiran Prescreening for CVOT | 2023 |
| 2022-07-21 | PFIZER INC. | Care Access Albany | $2,495 | A PHASE 3 MULTICENTER PLACEBOCONTROLLED RANDOMIZED OBSERVERBLINDED TRIAL TO EVALUATE THE EFFICACY SAFETY TOLERABILITY IM | 2022 |
| 2021-09-16 | Regeneron Pharmaceuticals, Inc. | CLINICAL RESEARCH SOLUTIONS LLC | $166 | A PHASE 3 RANDOMIZED, DOUBLE-BLIND, MULTI-DOSE, PLACEBO AND NAPROXEN-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFET | 2021 |
| 2020-07-29 | Regeneron Pharmaceuticals, Inc. | CLINICAL RESEARCH SOLUTIONS LLC | $166 | A PHASE 3 RANDOMIZED, DOUBLE-BLIND, MULTI-DOSE, PLACEBO AND NAPROXEN-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFET | 2020 |
| 2019-01-14 | Shionogi Inc | Clinical Research Solutions | $2,061 | Study of S-033188 Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complication | 2019 |
| 2019-01-14 | Shionogi Inc | Clinical Research Solutions | $1,729 | Study of S-033188 Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complication | 2019 |
| 2019-01-14 | Shionogi Inc | Clinical Research Solutions | $1,680 | Study of S-033188 Compared With Placebo or Oseltamivir in Patients With Influenza at High Risk of Influenza Complication | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Bellbrook, OH, county Greene County, OH, state Ohio; placed by its city name.
| Measure | Place (city or town) Bellbrook, OH | County Greene County, OH | State Ohio |
|---|---|---|---|
| Population B01003 | 7,394 | 169,688 | 11,810,293 |
| Population, 2020 census P1 | 7,317 | 167,966 | 11,799,448 |
| Median age B01002 | 43.5 | 38.7 | 39.7 |
| Under 18 B01001 | 19.3% | 20.6% | 22.0% |
| 65 and over B01001 | 19.3% | 18.6% | 18.3% |
| Households B11001 | 3,027 | 68,166 | 4,863,191 |
| Foreign born B05002 | 5.1% | 4.7% | 5.2% |
| Median household income B19013 | $111,513 | $87,309 | $71,389 |
| Median family income B19113 | $128,214 | $114,959 | $92,749 |
| Per capita income B19301 | $51,307 | $45,142 | $40,552 |
| Poverty rate B17001 | 3.3% | 9.8% | 13.3% |
| Unemployment rate B23025 | 0.6% | 4.3% | 4.8% |
| Civilian labor force B23025 | 3,718 | 85,091 | 5,994,779 |
| Mean commute (minutes) B08013 | 22.7 | 22.0 | 23.4 |
| Bachelor's degree or higher B15003 | 50.4% | 41.7% | 31.5% |
| Housing units B25001 | 3,084 | 72,391 | 5,292,391 |
| Owner-occupied B25003 | 80.7% | 68.0% | 67.2% |
| Renters B25003 | 19.3% | 32.0% | 32.8% |
| Median home value B25077 | $264,300 | $252,200 | $214,800 |
| Median gross rent B25064 | $1,346 | $1,135 | $1,034 |
| White, not Hispanic B03002 | 88.6% | 81.3% | 75.8% |
| Black B03002 | 0.5% | 5.8% | 12.0% |
| Hispanic or Latino B03002 | 1.9% | 3.3% | 4.8% |
| Asian B03002 | 4.0% | 3.0% | 2.5% |
| American Indian and Alaska Native B03002 | 0.0% | 0.1% | 0.1% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Bellbrook, OH.
Comments